Bharat Parenterals Closes Trading Window for Insider Trading

Bharat Parenterals Ltd has announced the closure of its trading window for dealing in equity shares, effective October 1, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and will remain in effect until 48 hours after the declaration of Un-audited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026. Designated Persons and their immediate relatives are prohibited from trading during this period. The company will also facilitate the freezing of PANs of Designated Persons and their relatives at the depository portal as per SEBI circulars. The date of the Board Meeting to approve these financial results will be intimated later.